Colitis, Ulcerative Clinical Trials in Orlando, Florida
4 studies are recruiting for colitis, ulcerative in Orlando, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Scor…
- Stage
- Phase 2
- Ages
- 18 to 75
- Site
- AdventHealth Orlando ( Site 1074), Orlando, Florida
- Locations
- 35 in total
- Run by
- Merck Sharp & Dohme LLC
-
Confirmatory Clinical Study in Active Ulcerative Colitis
The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found to have favorable effects. In this study, 2 different doses will be tested, and long-term treatment effects will be investigated. MH002 is a live bio…
- Stage
- Phase 2
- Ages
- 16 and older
- Site
- Orlando Gastroenterology, P.A., Orlando, Florida
- Locations
- 25 in total
- Run by
- MRM Health NV
-
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to c…
- Stage
- Phase 2
- Ages
- 2 to 17
- Site
- Local Institution - 0075, Orlando, Florida
- Locations
- 90 in total
- Run by
- Bristol-Myers Squibb
-
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- Orlando Health/Digestive Health Institute, Orlando, Florida
- Locations
- 28 in total
- Run by
- Pfizer
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.